Perrigo has appointed Ron Winowiecki, senior vice president, business finance, as chief financial officer (CFO), effective immediately, following the resignation of Judy Brown, executive vice president, business operations and CFO, who is leaving Perrigo to take a position with another company on April 1, 2017. Perrigo is conducting a search process to identify a permanent CFO, which includes Mr. Winowiecki as a candidate.
Ron Winowiecki has served as Perrigo's senior vice president, business finance since January 2014. Before serving as senior vice president, Mr. Winowiecki was Perrigo's vice president, treasury and accounting shared services from September 2011 to December 2013 and corporate vice president, treasurer from October 2008 to August 2011. Prior to joining Perrigo, he served as CFO for Innotec Company, vice president corporate controller for SPX Corporation, and the corporate controller and chief accounting officer at Donnelly Corporation.
Perrigo also appointed Svend Andersen as executive vice president and president, Consumer Healthcare International (CHCI). The CHCI segment comprises the Branded Consumer Healthcare business as well as Perrigo's legacy international businesses. Mr. Andersen will be responsible for a portfolio mainly consisting of store brand and branded over-the-counter (OTC) medicines and products. He will report directly to Chief Executive Officer John Hendrickson and join Perrigo's executive committee.
Most recently, Mr. Andersen served as executive vice president, Europe, for LEO-Pharma. Prior to that, he led Hospira’s Europe, Middle East, and Africa (EMEA) business. While at Actavis, Mr. Andersen was responsible for the Western European division's pharmaceuticals, generics, OTC, and hospital products businesses, and also led Alpharma's EMEA businesses prior to its acquisition by Actavis.